Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
  • Current Issue
  • Past Issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • 100th Anniversary of Insulin's Discovery (Jan 2021)
    • Hypoxia-inducible factors in disease pathophysiology and therapeutics (Oct 2020)
    • Latency in Infectious Disease (Jul 2020)
    • Immunotherapy in Hematological Cancers (Apr 2020)
    • Big Data's Future in Medicine (Feb 2020)
    • Mechanisms Underlying the Metabolic Syndrome (Oct 2019)
    • Reparative Immunology (Jul 2019)
    • View all review series ...
  • Viewpoint
  • Collections
    • Recently published
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • Recently published
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
Increased ABCA1 activity protects against atherosclerosis
Roshni R. Singaraja, … , Bart Staels, Michael R. Hayden
Roshni R. Singaraja, … , Bart Staels, Michael R. Hayden
Published July 1, 2002
Citation Information: J Clin Invest. 2002;110(1):35-42. https://doi.org/10.1172/JCI15748.
View: Text | PDF
Article Cardiology

Increased ABCA1 activity protects against atherosclerosis

  • Text
  • PDF
Abstract

Research Article

Authors

Roshni R. Singaraja, Catherine Fievet, Graciela Castro, Erick R. James, Nathalie Hennuyer, Susanne M. Clee, Nagat Bissada, Jonathan C. Choy, Jean-Charles Fruchart, Bruce M. McManus, Bart Staels, Michael R. Hayden

×

Figure 1

Options: View larger image (or click on image) Download as PowerPoint
Expression of ABCA1 in BAC+ApoE–/– mice. Increased ABCA1 protein was det...
Expression of ABCA1 in BAC+ApoE–/– mice. Increased ABCA1 protein was detected in the liver, kidney, brain, aorta, gonad, large intestine (lg. int.), and in peritoneal macrophage cells isolated from the BAC+ApoE–/– mice (a). An anti-ABCA1 mAb raised against the second nucleotide-binding domain was used (top panel) to detect ABCA1. To ensure equal protein loading, the Western blots were probed with anti-GAPDH Ab (lower panel). (b) Human-specific ABCA1 transcript was detected in all tissues tested using RT-PCR. For each tissue, lane 1 is human specific, lane 2 is mouse specific, and lane 3 is an 18S control. The last panel is from a control mouse and contains no human transcript.
Follow JCI:
Copyright © 2021 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts